AI In the Public Interest: Authorship & Copyright in the Age of AI
The Briefing: Pepperdine’s Trademark Claim Against Netflix in “Running Point” Case Goes Under For Good
Episode 421 -- The Dangers of AI Mistakes
EEO-1 Reports, Remote Work, and Non-Compete Restrictions in Tennessee - Employment Law This Week®
The Briefing: UMG v. Quince: When Trending Audio Becomes Copyright Infringement
Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
Operation Bluebird, Inc. (“Bluebird”) and X Corp. are locked in a dispute over the future of the Twitter brand, stemming from the platform’s rebrand from “Twitter” to “X” in 2023. The TMCA covered the rebrand....more
When a company files for bankruptcy, Section 541 of the Bankruptcy Code creates a bankruptcy “estate” comprised of virtually all its interests in property. The estate includes the debtor’s interests in tangible assets, like...more
In the first installment of patents and politics, we reported that the United States was potentially entering into an era of IP policy driven by President Trump’s America First rhetoric. In March, Mr. John Squires,...more
AGI SURETRACK LLC v. FARMERS EDGE INC. - Before Moore, Mayer, and Lourie. Appeal from the District of Nebraska. Patents claiming data collection, processing, and transmission using generic computer components are...more
In this episode of The Briefing, Weintraub Tobin partners Scott Hervey and Tara Sattler discuss the court’s ruling, where Brandy Melville’s trademark claims fell short, and whether a different trademark argument could have...more
The first quarter of 2026 saw several meaningful Section 337 decisions from the U.S. International Trade Commission (“Commission”). These decisions addressed the domestic industry requirement, the impact of redesigned...more
Recently, the Federal Circuit affirmed the Eastern District of Michigan’s ruling that Ford Motor Company (“Ford”) misappropriated Versata Software Inc.’s (“Versata”) trade secrets and breached a software licensing agreement. ...more
The Supreme Court just handed generic manufacturers – and really, all patent defendants – a major win in Hikma v. Amarin, unanimously reversing the Federal Circuit and tightening the standard for induced infringement under §...more
A medical device company had an NDA. They had a jury award of more than $17 million. They had a permanent injunction against their competitor. The Federal Circuit reversed almost all of it....more
On June 8, 2026, Alvotech announced that the FDA accepted for review its abbreviated Biologics License Application (“aBLA”) for AVT16, a proposed interchangeable biosimilar to Takeda’s Entyvio® (vedolizumab). AVT16 is the...more
On June 2, 2026, the White House issued the Order which announces that it is “the policy of the United States to promote AI innovation and security by working collaboratively with the private sector to modernize government...more
The pharmaceutical industry has been watching Hikma Pharmaceutical USA Inc. v. Amarin Pharma, Inc. (No. 24-889) closely for its potentially sweeping implications for generic drug competition, as discussed in our prior posts –...more
The United States Patent and Trademark Office (USPTO) employs nearly 9,000 patent examiners to examine the utility patent applications, with provisions in the Fiscal Year 2026 (FY26) budget for hiring 1,500 more. However, the...more
When IP Strategy Feels Like Uncharted Territory, Hemant Gupta Knows the Terrain For technology and life sciences companies racing to innovate, protecting intellectual property (IP) can feel like an afterthought—until it...more
CLE Relay 2026 - As AI tools become embedded in business operations across sectors, the legal questions surrounding their use are growing more complex — and more consequential. Jenner & Block lawyers examine the latest...more
The US Court of Appeals for the Federal Circuit reversed a judgment awarding damages and a permanent injunction, finding that the plaintiff’s trade secret misappropriation claims were barred by the statute of limitations...more
Addressing patent eligibility and attorneys’ fees, the US Court of Appeals for the Federal Circuit affirmed a district court’s ruling that five farming data patents were directed to patent-ineligible subject matter, but...more
Addressing when a copyright ownership claim accrues under the Copyright Act, the US Court of Appeals for the Sixth Circuit reversed a summary judgment grant, finding that genuine disputes of material fact remained as to...more
In most commercially significant inventions, strategic filing of various types of “child” patent applications (patent applications extending from an original or “parent” patent application) in various worldwide jurisdictions...more
This article catalogs the principal categories of risk that corporate counsel should evaluate, with concrete examples and an eye toward the contract levers that can mitigate each one. Data is the fuel for AI systems, and the...more
In a decision that, in retrospect, is not surprising (in view of the haste with which the Court took up the case after granting certiorari; see “Solicitor General Proves Persuasive; Supreme Court Grants Hikma’s...more
The Trademark Trial and Appeal Board (“TTAB” or “the Board”) afforded no weight to a bare-bones trademark consent agreement that contained no provisions for the parties to avoid confusion, even though the same agreement had...more
What You Need to Know Unfair competition claims arise when a business alleges that a competitor, former employee, or business partner has engaged in improper conduct that damages its goodwill, customer relationships, or...more
The U.S. Court of Appeals for the Federal Circuit held that trade secret plaintiffs may seek unjust enrichment damages measured by a defendant's gains from misappropriated technology and ordered a new trial on trade secret...more
On June 4, 2026, a unanimous Supreme Court in Hikma Pharms. USA Inc. v. Amarin Pharma, Inc., No. 24-889, clarified the standard for pleading induced patent infringement under 35 U.S.C. § 271(b). ...more